Skip to main content
ICD-10-PCS/XW0/XW033G6
Inpatient Procedure Code

XW033G6

Introduction of REGN-COV2 Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6

Introduce REGN-COV2 in Periph Vein, Perc, New Tech 6

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
SectionX

New Technology

2
Body SystemW

Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body Part3

Peripheral Vein

5
Approach3

Percutaneous

6
Device / Substance / TechnologyG

REGN-COV2 Monoclonal Antibody

7
New Technology Group6

New Technology Group 6

Contextual Map

Every relationship of XW033G6 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

  • XW0[PCS table]
  • [object Object] — Section: [object Object] [Section]: “[object Object]”
  • [object Object] — Body System: [object Object] [Body System]: “[object Object]”
  • [object Object] — Operation: [object Object] [Operation]: “[object Object]”

Nearest codes

  • XW013G6 — Introduction of REGN-COV2 Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 [One axis away]
  • XW03396 — Introduction of Ceftolozane/Tazobactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 6 [One axis away]
  • XW033G5 — Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW033G7 — Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW033H6 — Introduction of Other New Technology Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6 [One axis away]
  • XW033L6 — Introduction of CD24Fc Immunomodulator into Peripheral Vein, Percutaneous Approach, New Technology Group 6 [One axis away]
  • XW043G6 — Introduction of REGN-COV2 Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 [One axis away]

Change history

No changes recorded for this code — unchanged since the FY2026 (April) baseline of the change ledger.